• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GNI Group Ltd

+ Add to Watchlist

3G6:GR

2.062 EUR 0.007 0.34%

As of 02:16:04 ET on 12/23/2014.

Snapshot for GNI Group Ltd (3G6)

Open: 2.061 Day's Range: 2.061 - 2.062 Volume: 0
Previous Close: 2.069 52wk Range: 1.600 - 4.047 1-Yr Rtn: -36.10%

Stock Chart for 3G6

No chart data available.
  • 3G6:GR 2.061
  • 1D
  • 1M
  • 1Y
2.069
Interactive 3G6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3G6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 232.41
Shares Outstanding (M) 112.71
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3G6

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 3G6

GNI Group Ltd. develops therapeutic pharmaceutical products utilizing Genome analysis. The Company targets diseases indigenous to Asian countries. GNI controls the whole process of drug discovery by conducting clinical trials, research and development, and marketing. The Company owns global subsidiaries in China and the US.

Ying LuoPresident/CEOHitoshi MatsudaDirector/COO
Thomas W EastlingDirector/CFO
More Company Profile & Key Executives for 3G6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil